Target CD7 CAR-T cells
GUT03
Phase 1 mab terminated
Quick answer
Target CD7 CAR-T cells for T-cell Acute Lymphoblastic Leukemia is a Phase 1 program (mab) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- China SXT Pharmaceuticals
- Indication
- T-cell Acute Lymphoblastic Leukemia
- Phase
- Phase 1
- Modality
- mab
- Status
- terminated